enGene Therapeutics Inc. (ENGN): 8-K filed Jun 15, 2026

Form type
8-K
Filing date
Jun 15, 2026
Accession number
0001193125-26-270384
Filer
enGene Therapeutics Inc. (CIK 1980845)